| Literature DB >> 27040314 |
Xinghong Zhao1, Jiao Xu2, Xu Song1, Ruilin Jia3, Zhongqiong Yin4, Anchun Cheng5, Renyong Jia3, Yuanfeng Zou1, Lixia Li1, Lizi Yin1, Guizhou Yue6, Cheng Lv1, Bo Jing1.
Abstract
Duck enteritis virus (DEV) is a double-stranded DNA virus belonging to the alphaherpesvirinae subfamily of the herpesviridae. Although vaccines were wildly used in controlling this disease, some infection could still not be prevented and led to significant economic losses as a result of mortality and decreased egg production. However, there is no antiviral drug against DEV. Resveratrol was identified to exert its antiviral activity by inhibiting the DEV replication in preliminary investigations. In the present study, we confirmed that resveratrol significantly reduced the mortality of ducklings which infected with a virulent strain of DEV. With resveratrol treatment, the survival rate increased by almost 80% at 8 days post infection (dpi). Pathological symptoms of ducklings caused by DEV were also relieved by resveratrol. The virus load in blood and tissues were effectively depressed when compared with the untreated group. In the assay of immune cytokines, the resveratrol exerted a dual-regulation effect. These results suggest that resveratrol is expected to be a new alternative control measure for DEV infection.Entities:
Keywords: Antiviral activity; Duck enteritis virus; Resveratrol
Mesh:
Substances:
Year: 2016 PMID: 27040314 DOI: 10.1016/j.antiviral.2016.03.014
Source DB: PubMed Journal: Antiviral Res ISSN: 0166-3542 Impact factor: 5.970